Bleeding from injuries to the torso
region is a leading cause of
fatalities in the military and in young adults. Such bleeding cannot
be stopped by applying direct pressure (compression) of a bandage.
An alternative is to introduce a foam at the injury site, with the
expansion of the foam counteracting the bleeding. Foams with an active
hemostatic agent have been tested for this purpose, but the barrier
created by these foams is generally not strong enough to resist blood
flow. In this paper, we introduce a new class of foams with enhanced
rheological properties that enable them to form a more effective barrier
to blood loss. These aqueous foams are delivered out of a double-barrelled
syringe by combining precursors that produce bubbles of gas (CO2) in situ. In addition, one barrel contains
a cationic polymer (hydrophobically modified chitosan, hmC) and the
other an anionic polymer (hydrophobically modified alginate, hmA).
Both these polymers function as hemostatic agents due to their ability
to connect blood cells into networks. The amphiphilic nature of these
polymers also enables them to stabilize gas bubbles without the need
for additional surfactants. hmC–hmA foams have a mousse-like
texture and exhibit a high modulus and yield stress. Their properties
are attributed to the binding of hmC and hmA chains (via electrostatic and hydrophobic interactions) to form a coacervate
around the gas bubbles. Rheological studies are used to contrast the
improved rheology of hmC–hmA foams (where a coacervate arises)
with those formed by hmC alone (where there is no such coacervate).
Studies with animal wound models also confirm that the hmC–hmA
foams are more effective at curtailing bleeding than the hmC foams
due to their greater mechanical integrity.